Form Type and Filing Date: This is a Form 8-K current report filed by CME GROUP INC. on February 2, 2026, reporting events as of that same date. Item 5.02 - Regulation FD Disclosure: The filing indicates disclosure under Regulation FD (Fair Disclosure), though the specific details of the disclosure are not fully visible in the provided document excerpt. Item 9.01 - Financial Statements and…

Our analysis rates this filing BULLISH. This 8-K filing represents a routine Regulation FD disclosure of standard pricing communications to CME Group clients. The identified risk (severity 3/10) is minimal and reflects normal exchange operations rather than material adverse developments. CME Group,…

Concern level: MODERATE (2.1/10). Key factors: One new low-to-moderate severity risk identified (severity 3/10) regarding pricing changes implementation; Potential for client reaction to fee adjustments, though this is routine for exchange operators; Lack of quantitative detail on pricing impact magnitude.

Notable risk changes: Routine pricing communication filed as Regulation FD disclosure - standard operational matter with minimal material impact; No material negative events, litigation, regulatory actions, or operational disruptions disclosed; Filing contains only boilerplate 8-K cover page and pricing notice - no substantive risk disclosures.

The model predicts CME will outperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.